NovoLogix, Inc. Receives EHNAC Healthcare Network Acc... ( EDEN PRAIRIE Minn. Aug. 2...)

NovoLogix, Inc. Receives EHNAC Healthcare Network Accreditation

Date:8/24/2009

EDEN PRAIRIE, Minn., Aug. 24 /PRNewswire/ -- NovoLogix, a cutting-edge Medical Pharmacy Benefit Management company, announces today it has achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC's HNAP accreditation recognizes excellence in health data processing and transactions, and indicates compliance with industry-established standards and HIPAA regulations.

Through the consultative review process, EHNAC evaluated NovoLogix in areas of privacy measures, systems availability and security infrastructure. In addition, EHNAC reviewed the organization's process of managing and transferring protected health information and determined that the organization meets or exceeds all EHNAC criteria and industry standards. Through completion of the rigorous accreditation process, the organization demonstrates to its constituents, adherence to strict standards and participation in the comprehensive, objective evaluation of its business.

"NovoLogix appears to have excellent controls in place around privacy and security, including a training program that is thorough, interesting, and in some cases remarkably creative. Additionally, the services provided and their audit trails were found to have high quality," said Ron Moser, Certified Information Systems Auditor of EHNAC.

NovoLogix equips organizations to deliver improved clinical and financial outcomes related to medical pharmacy for patients, providers and payers using an innovative suite of services. Their information system and services platform creates customizable, PBM-like capabilities, which effectively and efficiently manage drugs covered under the medical benefit.

"Through EHNAC HNAP accreditation, NovoLogix has demonstrated a commitment to ensuring the security and privacy of health data processing and trans
'/>"/>

SOURCE NovoLogix
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets
2. vProtect Luminal Shield (TM) from Prescient Medical Receives CE Mark
3. Integrated Medical Systems Receives $1.1 Million From the U.S. Department of Defense for Critical Enhancements of the Worlds First Suitcase Intensive Care Unit
4. EndyMed Medical Receives FDA Clearance for Painless, Non-invasive Anti-Wrinkle Treatment System
5. Sound Pharmaceuticals Receives an Office of Naval Research Award for Its Hearing Loss Research and Development
6. Mylans Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
7. The Blue Foundation for a Healthy Florida Receives Grant to Address National/Regional Nursing Shortages
8. Siemens Emotion CT Receives Top Rating in KLAS Report
9. Secure eHealth Partner Receives Patent and Notice of Patent Allowance that is Key to Enriched Data Portability in Healthcare
10. Mylan Pharmaceuticals Receives Final FDA Report and Reaffirms Its 48-Year Exemplary Record of Quality
11. Cystic Fibrosis Foundation Receives Second 4-Star Rating from Charity Navigator for Exceptional Fiscal Management

Post Your Comments:

(Date:12/16/2009)... -- Tyco International Ltd. (NYSE: TYC ... Daniels for election to the Tyco Board of ... March 10, 2010. ,, Daniels, 55, is ... group of International Business Machines Corporation. In this ... Services business operations consisting of outsourcing services, integrated ...

(Date:12/16/2009)... Dec. 16 Medizone International, Inc. (OTC ... Board of Directors and the Board of Medizone ... Medizone International Inc. holds a 50% interest, agreed ... venture and reconvey to Medizone International all global ... Medizone International,s Chairman, Edwin G. Marshall said, "Time ...

(Date:12/16/2009)... myopia now than in the ,70s, study finds , , ... more common in the United States than it was ... study shows. , Researchers compared National Health and Nutrition ... from 1971 to 1972 and from 8,339 black and ... 12 to 54 years old. , The prevalence of ...

(Date:12/16/2009)... triathalons and appeared on The Amazing Race , , ... think of herself as part human, part machine. , A ... triathlete likes to describe herself. When she,s not training for ... auditoriums or posing nude with her metal leg crossed over ... ESPN Body Issue. , She is the first ...

(Date:12/16/2009)... Unisense FertiliTech A/S has received a further 1.6 million Euro ... EmbryoScope™ Embryo Monitoring System in order to meet the rapidly growing ... LD Pensions and Unisense A/S that continue to own each about ... ... December 16, 2009 -- Unisense FertiliTech A/S has received a further ...

Breaking Medicine News(10 mins):Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2 Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2 Health News:Amputee Athlete Tells Her Story 2 Health News:Amputee Athlete Tells Her Story 3 Health News:Amputee Athlete Tells Her Story 4 Health News:Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device 2

[0] Tyco International Files Preliminary Proxy Proposing Election of New Director [0] Medizone International, Inc. Approves Repurchase of Global Marketing Rights [0] Nearsightedness on the Increase [0] Amputee Athlete Tells Her Story [0] Increased Capital Funding for Unisense FertiliTech A/S Will Help Meet Demand for New Assisted Reproduction Device

... FORCE BASE, May 24 When the space shuttle Atlantis ... Bicentennial Silver Dollars. This unique coin commemorates the birth ... the blind and is the first United States coin to ... be used to support the National Federation of the Blind ...

... sent to manufacturers by month,s end, CDC says , , ... reported progress towards a viable H1N1 swine flu vaccine ... Disease Control and Prevention saying they had two promising ... "Today CDC received, from one institution, a candidate vaccine ...

... injury takes practice, on and off the field, experts ... Just do it safely, says the American Academy of ... children aged 5 to 14 were treated for baseball-related ... medical settings, the U.S. Consumer Product Safety Commission notes. ...

... could be sent to manufacturers by month,s end, CDC ... viable H1N1 swine flu vaccine got a bit nearer ... promising candidate viruses for use in such a shot. ... vaccine virus," Dr. Anne Schuchat, the Centers for Disease ...

... founded by veteran attorney Bruce Abel, launches blog to help employers ... ... Los Angeles (Lexis Nexis) May 23, 2009 -- In an ... workers, rights and minimize the risk of employment litigation, Abel ...

... HAE:TSX- Loan of US$2.5 Million Expected to Close ... Haemacure Corporation (TSX:HAE), a Montreal-based specialty bio-therapeutics company, ... Vancouver (NASDAQ: ANPI , TSX:ANP) are preparing ... loan from Angiotech to Haemacure in the amount ...

National Federation of the Blind Congratulates NASA on Successful Mission U.S. Closer to Viable Swine Flu Shot For Young Ballplayers, Support and Caution Are Key U.S. Progressing on Swine Flu Vaccine Abel Law Offices Introduces Free Web Resource for California Employers Navigating Workplace Laws Haemacure Update on Proposed Collaboration and Bridge Financing

(Date:12/16/2009)... 16 The Boards of Silence Therapeutics ... to announce the merger of their businesses to ... RNAi (RNA interference). The enlarged company, to ... discovery, development and delivery technologies, a broad internal ... of intellectual property. ,, The Directors believe ...

(Date:12/16/2009)... Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) ... 3 registration clinical trial for KRX-0401 (perifosine), ... / refractory multiple myeloma patients. ,, The ... to Assess the Efficacy and Safety of ... (Velcade®) and Dexamethasone in Multiple Myeloma Patients ...

(Date:12/16/2009)... 16 , ... Daniel,Tome,s Supervision and Published* in November 2009, in ... Society "Bone", Reveal new Benefits for,Peptan(TM) in Osteoporosis ... to consumer concerns regarding long-term bone health,Rousselot has ... to demonstrate,that an oral intake of Peptan(TM) may ...

Breaking Medicine Technology:Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 2 Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 3 Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 4 Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 5 Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company 6 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6 Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7 Published in "Bone" Journal, Scientific Researches Confirm Peptan(TM) Hydrolyzed Collagen Benefits on Bone Health 2 GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 1 GBS CIDP Foundation International Appoints Patricia A Bryant as Executive Director 49276 2 Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 1 Cellular telephones to expand knowledge of health behaviors and microorganisms in adolescent males 49272 2 Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 1 Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 2 Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 3 Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 4

[0] Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company [0] Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma [0] Published in "Bone" Journal, Scientific Researches Confirm Peptan(TM) Hydrolyzed Collagen Benefits on Bone Health

... 2007 /PRNewswire-FirstCall/ --,CuraGen Corporation announced today that ... deacetylase (HDAC) inhibitor being,investigated for the treatment ... for the prevention of severe oral mucositis,will ... for Cancer,Research (AACR) 2007 Annual Meeting in ...

... April 11, 2007 /PRNewswire-FirstCall/ --,Advanced Magnetics today ... clinical trials of ferumoxytol as an,intravenous (IV) ... at approximately 6:00 pm EDT as posters ... in Orlando,Florida. These posters are available in ...

Other Medicine Technology:CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 2 CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 3 CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting 4 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 2 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 3 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 4 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 5 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 6 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 7 Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 8

CuraGen Announces New Preclinical Results with Belinostat and,Velafermin to be Presented at AACR Annual Meeting Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic

... With the increase in Endoscopic cases it is ... Monitor with the Surgical Light. This combination ... without having to adopt an uncomfortable pose. ... including the NUVO Monitoring System. As such ...

... This configuration offers all the performance of a ... perfectly for use in Outpatient Settings, Minor Procedure ... Mounting two single lights either side of the ... in a General OR when combining Flat Screen ...

A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....

Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously....

Medicine Products:

NUVO Surgical Light - Double Light Head Monitor Ready NUVO Surgical Light - Single Light Head Anti-Myelin Associated Glycoproteins (MAG) Western Blot Triturus® EIA Analyzer

NovoLogix, Inc. Receives EHNAC Healthcare Network Acc...( EDEN PRAIRIE Minn. Aug. 2...),Health